← FDA DRUG APPROVALS

FDA ANDA · ANDA078192

RANITIDINE

Sponsor: DR REDDYS LABS LTD

APPLICATION
ANDA078192
TYPE
ANDA
ORIGINAL APPROVAL
2007-08-31
LATEST ACTION
2015-11-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

RANITIDINE HYDROCHLORIDEOver-the-counter
RANITIDINE HYDROCHLORIDE EQ 150MG BASE · TABLET · ORAL

Approval history

2015-11-25Labeling · Supplement 14 · standardAP
2012-01-18Manufacturing (CMC) · Supplement 10AP
2007-08-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →